Skip to main content Skip to section navigation Skip to footer
CohBar, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Programs & Pipelines
    • Overview
    • Our Approach
    • CB5138-3
    • CB4211
    • CB5064 Analogs
    • Posters & White Papers
  • Patient Resources
    • Overview
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Partners
  • Careers
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
Jul 17, 2017 9:00am EDT

CohBar, Inc. Completes US$5.2 Million Private Placement

Jun 23, 2017 9:00am EDT

CohBar, Inc. Announces Private Placement Offering

Jun 01, 2017 4:15pm EDT

CohBar, Inc. to Hold 2017 Annual Shareholder Meeting and Investor Update June 15, 2017

May 15, 2017 9:00am EDT

CohBar, Inc. Announces First Quarter 2017 Financial Results

Mar 29, 2017 5:33pm EDT

CohBar, Inc.’s CEO Simon Allen to Present at the 1st Annual H.C. Wainwright & Co. NASH Investor Conference in New York

Mar 22, 2017 4:05pm EDT

CohBar, Inc. Announces Fourth Quarter 2016 Financial Results

Mar 03, 2017 11:00am EST

CohBar, Inc. to Announce Fourth Quarter 2016 Financial Results and Host Conference Call for Shareholders on March 22, 2017

Feb 21, 2017 8:30am EST

CohBar, Inc. Announces Positive Results from Preclinical NASH Study of its Lead Drug Candidates

Feb 09, 2017 8:30am EST

CohBar, Inc.’s CEO Simon Allen to Present at the 2017 BIO CEO & Investor Conference in New York

Feb 06, 2017 8:30am EST

CohBar Inc. Presentation Now Available for On-Demand Viewing

  • arrow_back
  • 1…
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • arrow_forward
©2022 CohBar, Inc. All Rights Reserved.
Privacy Policy Sitemap Terms of Use